Alphatec Holdings Inc. (ATEC) and West Pharmaceutical Services Inc. (NYSE:WST) Comparing side by side

Alphatec Holdings Inc. (NASDAQ:ATEC) and West Pharmaceutical Services Inc. (NYSE:WST) are two firms in the Medical Instruments & Supplies that compete against each other. Below is a comparison of their institutional ownership, analyst recommendations, profitability, risk, dividends, earnings and valuation.

Earnings and Valuation

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Alphatec Holdings Inc. 92.63M 0.75 11.64M -0.13 0.00
West Pharmaceutical Services Inc. 1.72B 4.48 206.90M 3.14 34.28

Table 1 demonstrates Alphatec Holdings Inc. and West Pharmaceutical Services Inc.’s gross revenue, earnings per share and valuation.


Table 2 hightlights the return on equity, return on assets and net margins of the two companies.

Net Margins Return on Equity Return on Assets
Alphatec Holdings Inc. -12.57% -62.6% -7.4%
West Pharmaceutical Services Inc. 12.03% 11.9% 8.2%

Risk and Volatility

Alphatec Holdings Inc. has a beta of 1.35 and its 35.00% more volatile than Standard & Poor’s 500. From a competition point of view, West Pharmaceutical Services Inc. has a 1.21 beta which is 21.00% more volatile compared to Standard & Poor’s 500.


The Current Ratio and a Quick Ratio of Alphatec Holdings Inc. are 2.4 and 1.5. Competitively, West Pharmaceutical Services Inc. has 2.9 and 2.2 for Current and Quick Ratio. West Pharmaceutical Services Inc.’s better ability to pay short and long-term obligations than Alphatec Holdings Inc.


West Pharmaceutical Services Inc. also pays out annual dividends at $0.57 per share and at a 0.55% dividend yield. No dividend is paid out for Alphatec Holdings Inc.

Analyst Ratings

The Ratings and Recommendations for Alphatec Holdings Inc. and West Pharmaceutical Services Inc. are featured in the next table.

Sell Ratings Hold Ratings Buy Ratings Rating Score
Alphatec Holdings Inc. 0 0 1 3.00
West Pharmaceutical Services Inc. 0 0 0 0.00

Alphatec Holdings Inc.’s upside potential currently stands at 150.00% and an $4 average target price.

Institutional & Insider Ownership

Roughly 26.8% of Alphatec Holdings Inc. shares are owned by institutional investors while 93.8% of West Pharmaceutical Services Inc. are owned by institutional investors. Insiders owned 16.1% of Alphatec Holdings Inc. shares. Competitively, West Pharmaceutical Services Inc. has 0.6% of it’s share owned by insiders.


Here are the Weekly, Monthly, Quarterly, Half Yearly, Yearly and YTD Performance of both pretenders.

Performance (W) Performance (M) Performance (Q) Performance (HY) Performance (Y) Performance (YTD)
Alphatec Holdings Inc. -10.7% -20.13% -23.66% -29.03% -4.35% -9.02%
West Pharmaceutical Services Inc. -1.77% -3.18% -8.04% 10.64% 8.04% 9.07%

For the past year Alphatec Holdings Inc. has -9.02% weaker performance while West Pharmaceutical Services Inc. has 9.07% stronger performance.


West Pharmaceutical Services Inc. beats Alphatec Holdings Inc. on 12 of the 13 factors.

Alphatec Holdings, Inc., a medical technology company, focuses on the design, development, manufacture, and marketing of products for the surgical treatment of spine disorders. Its product and procedural portfolio, as well as pipeline address the cervical, thoracolumbar, and intervertebral regions of the spine; and cover various spinal disorders and surgical procedures. The company offers MIS products consisting of Battalion Lateral Spacer System and Squadron Lateral Retractor, XYcor Expandable Spinal Spacer System, Illico Minimally Invasive Surgery System, and BridgePoint Spinous Process Fixation System; and thoracolumbar fixation products, such as Arsenal Degenerative, Arsenal Deformity, Arsenal CBx Cortical Bone Fixation, and Zodiac Degenerative Spinal Fixation systems. It also provides cervical and cervico-thoracic products, including Trestle Luxe Anterior Cervical Plate System, as well as Solanas Posterior Cervico/Thoracic Fixation System and Avalon Occipital Plate; and interbody systems, such as Battalion Universal Spacer System, Novel PEEK and Titanium Spinal Spacers, and Alphatec Solus Locking ALIF Spinal Spacer. In addition, the company offers biologics consisting of AlphaGraft Structural Allograft Spacers, AlphaGraft ProFuse Demineralized Bone Scaffold, Amnioshield Amniotic Tissue Barrier, Alphagraft Demineralized Bone Matrix, and Neocore Osteoconductive Matrix. It sells its products through a network of independent distributors and direct sales representatives in the United States. Alphatec Holdings, Inc. was founded in 1990 and is headquartered in Carlsbad, California.

West Pharmaceutical Services, Inc. manufactures and sells packaging components and delivery systems for injectable drugs and healthcare products in the United States, Germany, France, Other European countries, and internationally. The companyÂ’s Proprietary Products segment offers stoppers and seals for injectable packaging systems; and syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies. It also provides drug containment solutions, including CZ vials, syringes, and cartridges; and self-injection systems, as well as specialized testing services for drug packaging, devices, and administration systems. This segment serves biologic, generic, and pharmaceutical drug companies. Its Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment serves pharmaceutical, diagnostic, and medical device companies. The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.